To the full analysis
Huron Consulting Group stock: growth
HURNHuron Consulting Group reported $1.7B in revenue for fiscal 2025, up 14.3% on the prior year, up 15% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
9.2%
per year from 2006 to 2025, per share 8.8%
Earnings (Annual rate)
7.5%
per year from 2006 to 2025, per share 7.1%
Free cash flow (Annual rate)
11.2%
per year from 2006 to 2025, per share 10.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 15.0% | 9.3% | 9.2% |
| Revenue per share | 20.4% | 11.9% | 8.8% |
| Earnings | no data | 5.9% | 7.5% |
| Earnings per share | no data | 8.5% | 7.1% |
| Free cash flow | 8.7% | 2.4% | 11.2% |
| Free cash flow per share | 13.8% | 4.8% | 10.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $321.92M | $26.69M | $24.43M |
| 2007 | $547.95M | $41.9M | $34.78M |
| 2008 | $615.48M | $40.65M | $81.38M |
| 2009 | $679.54M | −$32.87M | $107.44M |
| 2010 | $604.6M | $8.53M | $41.55M |
| 2011 | $657.89M | $20.52M | $94.68M |
| 2012 | $625.96M | $36.43M | $83.95M |
| 2013 | $538.13M | $66.43M | $93.46M |
| 2014 | $627.69M | $79.05M | $120.54M |
| 2015 | $699.01M | $59.05M | $144.83M |
| 2016 | $726.27M | $37.62M | $113.29M |
| 2017 | $732.57M | −$170.12M | $74.02M |
| 2018 | $795.13M | $13.65M | $86.65M |
| 2019 | $876.76M | $41.74M | $108.67M |
| 2020 | $844.13M | −$23.72M | $120.34M |
| 2021 | $905.64M | $62.99M | $2.23M |
| 2022 | $1.13B | $75.55M | $61.1M |
| 2023 | $1.36B | $62.48M | $100.08M |
| 2024 | $1.49B | $116.63M | $192.67M |
| 2025 | $1.7B | $105.04M | $182.96M |
Revenue by segment
How Huron Consulting Group Inc. makes its money and how that has shifted. Names are as the company reports them.
- Healthcare51%
- Education30%
- Commercial19%
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| Healthcare | $535M | $673.99M | $777.44M | $858.42M | 50.5% |
| Education | $359.84M | $429.66M | $483.54M | $509.51M | 30% |
| Commercial | $237.62M | $258.41M | $260.83M | $331.21M | 19.5% |
| Total revenue | $1.13B | $1.36B | $1.49B | $1.7B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 15 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.